#meningococcal vaccines market value
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Tumblr has a low social media market share in South America.
Link
0 notes
Text
Pediatric Vaccines is Estimated to Witness High Growth Owing to Increased Government
Pediatric vaccines are vaccines administered to children during early life. Some of the key pediatric vaccines available in the market include pneumococcal vaccines, polio vaccines, MMR (measles, mumps, and rubella) vaccines, hepatitis vaccines, rotavirus vaccines, meningococcal vaccines, influenza vaccines, among others. These vaccines help prevent various life-threatening diseases and infections in children. Increased government initiatives to promote immunization programs globally have played a key role in improving children’s immunization rates. The global Pediatric Vaccines Market is estimated to be valued at US$ 46,424.3 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Increased government immunization programs present a key growth opportunity for the pediatric vaccines market. Various governments across the world are investing heavily in mass immunization programs to ensure high immunization rates among children. For instance, the Indian government’s Universal Immunization Program (UIP) aims to immunize all children up to 2 years of age against twelve vaccine-preventable diseases. Similarly, governments in the U.S., UK, China, Brazil and others are implementing effective nationwide immunization programs. The strong impetus by governments to promote immunization is expected to drive the demand for pediatric vaccines, especially in developing regions. This will encourage vaccine manufacturing companies to develop new and improved pediatric vaccines to capitalize on this opportunity. Porter’s Analysis Threat of new entrants: New entrants face high costs associated with R&D, clinical trials, and licensing requirements. Stringent regulations imposed by regulatory bodies further increase barriers. Bargaining power of buyers: Buyers have low bargaining power as vaccines market is highly consolidated and R&D for new vaccines requires huge investments. Switching costs for buyers are also high. Bargaining power of suppliers: Suppliers have moderate bargaining power due to specialized expertise and long term contracts with manufacturers. However, presence of alternatives balances it. Threat of new substitutes: Threat of substitutes is low as vaccines have few alternatives for preventing infectious diseases. Competitive rivalry: Market is dominated by few global players. Intense competition exists on the basis of portfolio expansion and vaccines pricing. SWOT Analysis Strength: High unmet needs for new vaccines and immunization programs. Increasing government support and initiatives to promote immunization. Weakness: High R&D costs and stringent regulations increase entry barriers. Pipeline depends on success rate of clinical trials. Opportunity: Emerging economies provide high growth potential. Collaborations aid expansion into new geographies and product lines. Threats: Pricing pressures to make vaccines affordable. Outbreaks of contagious diseases challenge current immunization. Key Takeaways The global pediatric vaccines market is expected to witness high growth over the forecast period. Vaccines are the most effective way to prevent infectious diseases in children. However, limited availability and affordability in developing nations persists. The global Pediatric Vaccines Market is estimated to be valued at US$ 46,424.3 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023-2030. Key players operating in the pediatric vaccines market are GlaxoSmithKline, Merck, Sanofi, Pfizer, and Mylan. GlaxoSmithKline leads the market with its wide portfolio of pediatric vaccine brands like Infanrix and Pediarix. New vaccines in pipeline focusing on respiratory infections, meningococcal disease, and Ebola can further aid market expansion.
0 notes
Text
Meningococcal Vaccine Market Size to 2031
The global meningococcal vaccine market size was valued at USD 2.76 billion in 2022. It is estimated to reach USD 6.14 billion by 2031, growing at a CAGR of 9.3% during the forecast period (2023–2031).
0 notes
Text
Paediatric Vaccine industry Growth, Trends Analysis Report 2032
According to a new report published by Future Market Insights titled for paediatric vaccines is anticipated to reach a value of US$ 48.8 billion by the end of 2022 and to grow at a CAGR of 12.7% to US$ 160.7 billion by 2032. In 2021, the global market will be led by the pneumococcal vaccination by indication, with a share of roughly 31.9%, according to a recent analysis by Future Market Insights.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion of healthcare expenditure in the recent times. The paediatric vaccine market is segmented according to indication, technology and vaccine type. According to the indication, the paediatric vaccine market is sub segmented into pneumococcal, DTP, rotavirus, influenza, meningococcal, hepatitis B, Hib, MMR and polio. According to technology the market is further segmented into live or attenuated, inactivated or killed, toxoid, conjugate, subunit and recombinant vaccines. By vaccine type, the global paediatric vaccine market is segmented into monovalent and multivalent vaccines.
A slew of routine immunisation initiatives rolled out by the government and private agencies has broadened the market for the paediatric vaccines. A new wave of funds pumped into the market by different government and private players to cork the rise of the child deaths across the globe has also opened a new window of opportunity for the paediatric vaccine market. As per the report of WHO (World Health Organization), the global spending on immunisation soared from US$21.4 to US$26.9 per infant in 2014. The massive economic boom in some regions of the world is expediting the growth of the paediatric vaccine market.
Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1317
Segmentation analysis
By indication, pneumococcal segment accounted for higher revenue share in global paediatric vaccines as compared to other product segments. The pneumococcal segment is expected to reach a value of US$ 31.58 Bn by 2026, reflecting a CAGR of 14.4% over the forecast period. The growth of pneumococcal segment is attributed to the increasing incidence of infectious diseases.
In terms of revenue, Hib vaccine segment is the second most growing segment and is expected to reach a value of US$ 13.49 Bn by 2026, growing at a CAGR of 13.4%. Hepatitis B and meningococcal segment are expected to show double-digit CAGR growth in the forecast period contributing to the growth of global paediatric vaccine market.
By technology, conjugate segment accounted for highest revenue share in global paediatric vaccine market as compared to live or attenuated segment. The conjugate segment is expected to reach a value of US$ 32.09 Bn by 2026, reflecting a CAGR of 14.8% over the forecast period. This is expected to be closely followed by the growth of pneumococcal and meningococcal vaccines in this segment
By end user, institutional health centres account for higher demand for paediatric vaccine as compared to other end user segments such as hospital pharmacies and retail pharmacies. The strong growth in institutional health centres can be attributed to increasing government interventions in immunisation programs in order to improve vaccine coverage. Institutional health centres are expected to register highest CAGR of 13.8% over the forecast period.
Get a Customized Scope to Match Your Need Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1317
Regional analysis
By region, North America is dominating the global paediatric vaccine market due to improved healthcare infrastructure in this region. The North America paediatric vaccine market is expected to be valued at US$ 20.15 Bn by 2026 growing at a CAGR for 11.0%. In addition to North America, demand for paediatric vaccines has been significantly growing in Western Europe and APEJ. APEJ is expected to grow at a CAGR for 14.9% over the forecast period and is expected to dominate the market by 2026 by generating revenue of US$ 22.69 Bn and revenues in Western Europe are anticipated to grow by 11.2%. Middle East and Africa is expected to grow at a CAGR of 12.6% and this growth is anticipated by growth government intervention for immunisation by carrying out national level immunisation campaigns and also disease specific immunisation campaigns.
Key players in the global paediatric vaccine market include
Indian Immunologicals,
GlaaxoSmithKline Plc.,
Pfizer Inc.,
Sanofi, Merck & Co. Inc.,
Panacea Biotec,
Zydus Cadila,
Emergent BioSolutions Inc.,
Serum Institute of India Pvt. Ltd.,
Bharat Biotech.
The growth of paediatric vaccine market is attributed to the development in the research by key players in the field, for instance, in February 2016, GSK submitted US regulatory submission for expanding the indication of FLuLaval Quadrivalent, influenza vaccine, for infants more than 6 months. These developments will boost the growth of the global paediatric vaccine market.
Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1317
Market Segmentation
Region
North America
Latin America
Western Europe
Eastern Europe
APEJ
MEA
Japan
Technology
Live or Attenuated Vaccine
Inactivated or Killed Vaccine
Toxoid Vaccine
Conjugate Vaccine
Subunit Vaccine
Recombinant Vector Vaccine
Indication
Pneumococcal Conjugate Vaccine
DTP Vaccine
Influenza
Meningococcal Vaccine
Polio Vaccine
Rotavirus Vaccine
MMR Vaccine
Varicella Virus Vaccine
End User
Hospital Pharmacies
Retail Pharmacies
Institutional Health Centres
Vaccine Type
Monovalent Vaccines
Multivalent Vaccines
0 notes
Text
Impact of COVID-19 Analysis: Meningococcal Vaccines Market Growth & Demand | Forecast – 2025
Meningococcal Vaccines Market driven by the Increasing rising prevalence of meningitis. The global industry is segmented on the basis of treatment, end user, and region - Forecast till 2025. The report is published by Market Research Future (MRFR)
Meningococcal Vaccines Market Overview
The global Meningococcal vaccines market showcases the rising cases of this disease with the increasing demand for vaccines. According to the report, almost 10 to 15 in 100 people get affected with meningococcal disease. The escalation in positive result cases and the need for vaccines is boosting its demand in the global market. The Meningococcal vaccines market has risen upto USD 172 million in the year 2019 and the global supply is estimated to be 203 million doses for the forecast period till 2025.
Despite broad and effective commitment from the global health community in meningitis A (MENA) vaccination in the meningitis belt, low manufacturing capacity and high prices across other meningococcal vaccine types have hindered access to these vaccines over the past several years. A more in-depth knowledge will benefit addressing these long-standing access issues and the development of the WHO global roadmap for overcoming meningitis by 2030. This is expected to set goals for disease control and vaccination for meningococcal meningitis on a global level.
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/8622
Meningococcal Vaccines Market Key Players
Some of the key players in the Global Meningococcal Vaccines Market are Baxter International, Pfizer Inc., Novartis Pharmaceuticals Canada Inc, Sanofi S.A., JN-International Medical Corporation, Biomed Pvt. Ltd., Serum Institute of India Ltd., and GlaxoSmithKline among others.
Market Segmentation
The global Meningococcal vaccines market is a booming market with a lot of investment and developments. The Global Meningococcal Vaccines Market has been segmented based on treatment and end-user.
Based on the treatment, the global product market can be divided into polysaccharide, meningococcal A conjugate vaccine, and subcapsular vaccine. The meningococcal conjugate vaccine is mostly used in mass campaigns in affected regions of Africa. Since 2010, the demand for such vaccines has been uncertain, based on the national immunization programs that are being adopted based on the country’s effectiveness and readiness to tackle the disease. Moreover, the demand and supply for Subcap MenB vaccines is a desirable combination that will moderate the global product scenario.
By the end-user, the global vaccine market can be split into research laboratories, hospital and clinical, and academic institutes. The hospitals and clinics segment holds major share in the global market for meningococcal vaccines.
Regional Analysis
In the global market, China is expected to have the largest market share, which accounts for approximately 35% of the global demand. This is primarily due to polysaccharide products, which currently comprise 84% of China’s demand.
During 2016-2018, UNICEF introduced the meningococcal conjugate vaccine in 26 countries and Ghana was the first country in Africa to receive this vaccination. Currently, the meningococcal vaccine has reached across different regions, in the most remote locations, and has increased in demand and supply in the global market.
Meningococcal Vaccines Market Industry News
In 2018, Pfizer granted FDA Breakthrough Therapy designation for Trumenba (Meningococcal Group B Vaccine). This vaccine plays a major role in the prevention of invasive meningococcal B disease in children aged 1 to 9 years.
In 2018, GSK’s (GlaxoSmithKline) meningitis B vaccine Bexsero received breakthrough therapy designation from the US FDA for prevention of Invasive Meningococcal Disease for children 2-10 years of age.
Browse Complete Report with TOC with COVID-19 Impact Analysis @ https://www.marketresearchfuture.com/reports/meningococcal-vaccines-market-8622
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: [email protected]
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
#meningococcal vaccines market#meningococcal vaccines market size#meningococcal vaccines market share#meningitis market#meningococcal vaccines market outlook#meningococcal vaccines market value
0 notes
Text
0 notes
Text
Vaccines Market Size, Share, and COVID-19 Impact Analysis | Analysis and Forecast 2022 – 2028
The N95 Grade Medical Protective Mask Market was valued at USD 1076.02 million in 2021. The market is projected to grow USD 2033.83 million in 2028 at a CAGR of 9.5 %.
The global Vaccines market research gives a detailed and practical analysis of the products and services in this market which provides a competitive advantage to the existing and new businesses. In depth study and overview of the market has been collected by the overall insight of the industry and specifies the market segmentation, potential opportunities, growing market trends and events, current and future advancements, and other elements. This report will also showcase many possibilities of upscaling the global Vaccines market share size.
The global business has experienced a major impact of the COVID-19 pandemic. This study report represents a critical turning point for the Vaccines industry and provides useful data to businesses to understand market challenges such as sloth in business activity due to the strict lockdowns globally.
Get a Sample PDF of Report — https://www.extrapolate.com/sample/Healthcare-Medical-Devices-Biotechnology/vaccines-market/18966
The competitive landscape of Vaccines market includes major players such as:
GlaxoSmithKline plc. (UK)
Merck & Co., Inc. (US)
Pfizer, Inc. (US)
Sanofi (France)
CSL Limited (Australia)
Emergent BioSolutions, Inc. (US)
Johnson & Johnson Services, Inc. (US)
AstraZeneca (UK)
Serum Institute of India Pvt. Ltd. (India)
Bavarian Nordic A/S (Denmark)
Mitsubishi Tanabe Pharma Corporation (Japan)
Daiichi Sankyo Company, Limited (Japan)
Panacea Biotec, Ltd. (India)
Biological E Limited (India)
Bharat Biotech Ltd. (India)
Novavax, Inc. (US)
FSUE NPO Microgen (Russia)
Sinovac Biotech, Ltd. (China)
Incepta Vaccine Limited (Bangladesh)
Valneva SE (France)
VBI Vaccines (US)
PT Bio Farma (Persero) (Indonesia)
Inovio Pharmaceuticals, Inc. (US)
Chongqing Zhifei Biological Products Co., Ltd. (China)
Indian Immunologicals Limited (India)
However, with relaxations in lockdown rules and regulations by the government, it can be said that the industry is stepping towards the potential growth and is anticipated to record a substantial revenue generation in the near future.
Additionally, this study report covers the latest business models and represents the range of expansion of the global market. Anticipation of manufacturing new products and providing latest services also mentioned in the study which will end up being profitable for the economic environment of the Vaccines market. It also provides details of various attributes of the market that have been changed over the time such as market size, supply and Vaccines market demand.
Inquire Before Buying This Research Report: https://www.extrapolate.com/enquire/Healthcare-Medical-Devices-Biotechnology/vaccines-market/18966
SEGMENTATION
By Technology
Live Attenuated Vaccines
Conjugate Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccines
By Disease Indication
Pneumococcal Disease
Influenza
Human Papillomavirus
Meningococcal Disease
Rotavirus,
Varicella
Diphtheria
Pertussis, and Tetanus {DPT}
Polio
Hepatitis
Measles,Mumps, and Rubella {MMR}
Other Indicators
By Region
North America- U.S., Mexico, Canada
Europe- UK, France, Germany, Italy, Spain, Rest of Europe
Asia-Pacific- China, Japan, India, South Korea, Rest of Asia Pacific
South America- Brazil, Argentina, Colombia, Rest of South America
The Middle East and Africa- GCC, South Africa, Rest of Middle East & Africa
The research report delivers several marketing strategies and a robust backup plan for companies working in the Vaccines industry. The study lists a brief data about firms standing in the market, their long-term goals, market size, market share, and their value of presence at the global level of the market.
The global Vaccines market research report includes geographical market segmentation in the regions of Asia Pacific, North America, South America, Europe, Africa, and the Middle East. It also examines market predictions depending on the regional areas around the globe that will help the businesses to understand the market and how they can maintain their position in the same. The study of this report includes region-wise Vaccines market size along with estimations of potential market growth opportunities.
Detailed TOC of Global Vaccines Market @ https://www.extrapolate.com/toc/Healthcare-Medical-Devices-Biotechnology/n95-grade-medical-protective-mask-market/18974
TABLE OF CONTENTS:-
Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. COVID-19 Impact On Vaccines Market
Chapter 5. Global Vaccines Market Overview, By Technology, 2015–2028(USD Million)
Chapter 6. Global Vaccines Market Overview, By Disease Indication, 2015–2028(USD Million)
Chapter 7. Global Vaccines Market Overview, By Distribution Channel, 2015–2028(USD Million)
Chapter 8. Global Vaccines Market Overview, By Geography, 2015–2028(USD Million)
About Us
Extrapolate is a global market research and content services firm that works closely with clients in various industries to improve market position, increase returns on marketing investments, and define and implement strategies that get real results.
In an era of breakneck change and a low tolerance for missed or misread opportunities, businesses need astute guidance to shape markets-not merely respond to them. Extrapolate helps clients develop market perspectives that drive commercial success.
Contact Us: Extrapolate Phone: (+1) 888 328 2189 E-mail: [email protected] Website: https://www.extrapolate.com
#Vaccines Market Size#Vaccines Market#Vaccines#Vaccines Market market#Vaccines Market growth#Vaccines Market overview
0 notes
Text
0 notes
Text
Vaccines Market to Represent Healthy Growth by 2028 & COVID-19 Impact
The Vaccines Market was valued at USD 61.04 billion in 2021 and is projected to grow USD 125.5 billion in 2028, at a CAGR of 10.85%.
Vaccines, also known as immunizations, are a key component of primary health care. Vaccines reduce the risks of contracting diseases by working with the body’s natural defenses system to build protection. According to the World Health Organization (WHO), vaccines currently prevent 2-3 million deaths every year from diseases such as tetanus, diphtheria, pertussis, measles, and influenza. Growing awareness and increasing investment by the government are boosting sales.
Get Sample Link Here : https://extrapolate.com/sample/Healthcare-Medical-Devices-Biotechnology/vaccines-market/18966?utm_source=poonam&utm_id=poonam
COVID-19 ANALYSIS
The pandemic had a severe impact on the Vaccine Market. The COVID-19 pandemic has exerted pressure on the vaccine manufacturers to increase production and supply of products. In addition, a majority of pharmaceutical, and healthcare organizations have concentrated on the production of treatment vaccines, diagnostics kits, and medication against the Novel Coronavirus, which led to increased production and demand for the vaccine, during the forecast period. Moreover, pharmaceutical companies are prioritizing research and development of coronavirus-related diagnostics, and treatments, as well as looking at the potential of existing treatments. These factors are propelling the growth of the market.
KEY INDUSTRY PLAYERS
Prominent market players have focused on strengthening their market positions with several product offerings. For instance, GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Pfizer, Inc. (US), Sanofi SA (France), CSL Limited (Australia), Emergent BioSolutions, Inc. (US), Johnson & Johnson (US), AstraZeneca plc (UK), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic A/S (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo Company, Limited (Japan), Panacea Biotec, Ltd.
SEGMENTATION
By Technology
Live Attenuated Vaccines
Conjugate Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccines
By Disease Indication
For Buying Report : https://extrapolate.com/Healthcare-Medical-Devices-Biotechnology/vaccines-market/18966?utm_source=poonam&utm_id=poonam
Pneumococcal Disease
· Influenza
· Human Papillomavirus
· Meningococcal Disease
· Rotavirus,
· Varicella
· Diphtheria
· Pertussis, and Tetanus {DPT}
About Us
Kings Research is a data proficient market research firm that specializes in fostering efficient insights that propels businesses. We specialize in providing business intelligence on product specific markets to gain insights on quantifiable data. And our aim is to be the development catalyst to our clients that deliver actionable insights.
Any special requirements about this report, please let us know and we can provide custom report.
0 notes
Text
Global Metabotropic Glutamate Receptor Market Size, Share and Trends: Ken Research
Buy Now
The global Metabotropic Glutamate Receptor market was valued at .98 Million USD in 2020 and will grow with a CAGR of 12.17% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report” Global and Regional Metabotropic Glutamate Receptor Industry Status and Prospects Professional Market Research Report Standard Version 2021-2027” is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.
Request For Sample Report-https://kenresearch.com/sample-report.php?Frmdetails=NDcwMzYy
By Market Verdors:
Serum Institute (India)
Sanofi SA (France)
Pfizer (USA)
Nuron Biotech (USA)
JN-International Medical (USA)
By Types:
Polysaccharide Vaccines
Conjugate Vaccines
Combination Vaccines
Men B Vaccines
By Applications:
Meningitis
Septicemia
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
For More Information, refer to below link:-
Global Metabotropic Glutamate Receptor market Research Report
Related Reports
2021-2027 Global and Regional Macro-Micro Electrode Industry Status and Prospects Professional Market Research Report Standard Version
2021-2027 Global and Regional Heart Pump Devices Industry Status and Prospects Professional Market Research Report Standard Version
Follow Us
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
0 notes
Link
0 notes
Text
Travelers Vaccines Market Size Share 2021-2028
Market Overview
The Global Travelers Vaccines Market is expected to grow at a CAGR of 8.60% during the forecasting period (2021-2028).
A vaccines are a biological preparation that aids to fight against diseases and boost up the immunity. It contains an agent that is related to a disease causing organism and made from killed form of microbes. According to the World Health Organization (WHO), currently licensed vaccines are available to avoid over twenty five infections. The effectiveness of the vaccine depends on disease pathophysiology, the stain of the vaccine, ethnicity, the schedule of the vaccination, and genetic predisposition. As the globalization is rising, the international traveling will keep increasing, which in turn, creates the demand for travel vaccines. Moreover, the vaccines are broadly used as a preventive measure counter to the known infectious diseases. The travelers are educated to adhere to the region-specific immunization plan.
Download free sample: https://www.datamintelligence.com/download-sample/eggshell-membrane-market
Market Dynamics
The increase in the number of diseases and viruses that have afflicted the sector has increased swiftly in the past few decades, and certainly, not enough vaccinations have been developed against them. Now, the increased awareness has obliged people to take the necessary vaccinations available, without giving it a second thought.
Growing tourism and travel industry
Growing touring industry and surge in incidence of travel related diseases is the major growth driver for the traveler vaccine market. Growing investment for R&D of new vaccine by pharmaceutical and biotechnology companies and growing adoption of vaccine by international travelers has prompted the demand for traveler vaccines. Furthermore, the growing government initiatives and rising awareness through electronic & print media are the factors that are expected to enhance the growth of the market. However, lack of expertise for the production of vaccines and weak cold supply chain management are the factors that are limiting the growth of the market.
Low risk of serious side effects
Extreme low risk of serious side effects on fetus along with the suitable educational & awareness programs through the various nonprofit organization are factors that support the market gfowth. Rising inclinations for outsourcing of vaccine in the emerging and under developed countries offers opportunity to boosts the traveler’s vaccines market. It is expected to grow with the increase in outbound travel and increase in vaccination coverage due to its awareness.
COVID-19 Impact Analysis
COVID-19 has certainly hampered the growth of the travelers vaccine globally. The ban on the international travelling by the governments has declined the number of international visits in 2020. Therefore, the demand for travelers vaccine declined and led to the downfall in the maket value in 2020 and subsequent years. Post COVID-19, it is expected that the travel and tourism industry get boom and the demand for travelers vaccine also will gain traction due to increasing concern of health safety. Travelers vaccines have a very rapid growth in the upcoimg year due to this pandemic.
Segmentation Analysis
By Type
· Meningococcal Vaccine*
· Japanese Encephalitis Vaccine
· Yellow Fever Vaccine
· Hepatitis Vaccine
· Cholera Vaccine
· Others
By Application
· Tourists*
· Students
· Workers
· Others
Geographical Analysis
Based on geography, the study analyzes the travelers vaccines market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America is anticipated to hold largest share in the global travelers vaccines market
Geographically, the North America is likely to dominate the human vaccines market in the global market over the forecast period. The combination vaccines segment is expected to expand at a high share in North America, followed by the recombinant vaccines and attenuated vaccines segments. In Europe, increase in demand for vaccination and increase in R&D expenditure boost the traveler’s vaccines market. Moreover, Asia Pacific is an emerging market for traveler’s vaccine due to the improving healthcare infrastructure and rising government expenditures by organizing educational & awareness programs. In Middle East and African countries, the advancement of the healthcare industry and economy help to enhance traveler’s vaccine market. However, affordability issues are factors restraining the market growth. The Government of Saudi Arabia operates routine vaccination programs for influenza, flu, and other vaccines in the country that generate an opportunity in the traveler’s vaccine market.
Competitive Landscape
The travelers vaccines market is highly competitive, owing to the presence of big food brands. The key travelers vaccines players which are contributing to the growth of the global market include Baxter International, Abbott Laboratories, Crucell Vaccines, Pfizer Inc., Emergent BioSolutions, Hoffman-La Roche Ltd., Dynavax Technologies Corporation, GSK group of companies, Shenzhen Kangtay Biological Products Co. Ltd., Takeda Pharmaceuticals U.S.A. Inc., Zydus Cadila, among others. The major players are adopting new product launch and expansion strategies for global growth in the travelers vaccines market.
Baxter International, Inc.:
Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. Baxter International, Inc. has a product portfolio comprising essential renal and hospital products, including sterile IV solutions, acute and chronic dialysis, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. The company operates through the following segment: Europe, Americas, Middle East & Africa and Asia-Pacific.
Product Portfolio: The Company’s portfolio comprises critical care, hospital care, nutritional care, renal care and surgical care, among others. Baxter's Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat end-stage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis.
View full report: https://www.datamintelligence.com/research-report/travelers-vaccines-market
Enquiry before buying: https://www.datamintelligence.com/enquiry/eggshell-membrane-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866
Website: www.datamintelligence.com
0 notes
Text
Travelers Vaccines Market Factors, Opportunities to register a healthy growth rate Forecast 2021-2027
Travelers Vaccines Market 2021-2027
A New Market Study, Titled “Travelers Vaccines Market Upcoming Trends, Growth Drivers and Challenges” has been featured on fusionmarketresearch.
Description
This global study of the Travelers Vaccines market offers an overview of the existing market trends, drivers, restrictions, and metrics and also offers a viewpoint for important segments. The report also tracks product and services demand growth forecasts for the market. There is also to the study approach a detailed segmental review. A regional study of the global Travelers Vaccines industry is also carried out in North America, Latin America, Asia-Pacific, Europe, and the Near East & Africa. The report mentions growth parameters in the regional markets along with major players dominating the regional growth.
Request a Sample Report @ https://www.fusionmarketresearch.com/sample_request/Travelers-Vaccines-Market/40855
This report contains market size and forecasts of Travelers Vaccines in global, including the following market information: Global Travelers Vaccines Market Revenue, 2016-2021, 2022-2027, ($ millions) Global Travelers Vaccines Market Sales, 2016-2021, 2022-2027, (K Doses) Global top five Travelers Vaccines companies in 2020 (%) The global Travelers Vaccines market was valued at 3180.8 million in 2020 and is projected to reach US$ 4395.4 million by 2027, at a CAGR of 8.4% during the forecast period. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Travelers Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Travelers Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Doses) Global Travelers Vaccines Market Segment Percentages, By Type, 2020 (%) Meningococcal Vaccine Japanese Encephalitis Vaccine Yellow Fever Vaccine Hepatitis Vaccine Cholera Vaccine Other
Competitor Analysis The report also provides analysis of leading market participants including: Key companies Travelers Vaccines revenues in global market, 2016-2021 (Estimated), ($ millions) Key companies Travelers Vaccines revenues share in global market, 2020 (%) Key companies Travelers Vaccines sales in global market, 2016-2021 (Estimated), (K Doses) Key companies Travelers Vaccines sales share in global market, 2020 (%) Further, the report presents profiles of competitors in the market, key players include: GlaxoSmithKline Sanofi Pasteur Merck Pfizer CNBG Sanofi Pasteur MSD Serum Institute of India Biokangtai
Global Travelers Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Doses) Global Travelers Vaccines Market Segment Percentages, By Application, 2020 (%) Tourists Students Workers Others
Global Travelers Vaccines Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Doses) Global Travelers Vaccines Market Segment Percentages, By Region and Country, 2020 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa
Ask Queries @ https://www.fusionmarketresearch.com/enquiry.php/Travelers-Vaccines-Market/40855
Table of Contents
1 Introduction to Research & Analysis Reports 1.1 Travelers Vaccines Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by End Users 1.3 Global Travelers Vaccines Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats
2 Global Travelers Vaccines Overall Market Size 2.1 Global Travelers Vaccines Market Size: 2021 VS 2027 2.2 Global Travelers Vaccines Revenue, Prospects & Forecasts: 2016-2027 2.3 Global Travelers Vaccines Sales (Consumption): 2016-2027
3 Company Landscape 3.1 Top Travelers Vaccines Players in Global Market 3.2 Top Global Travelers Vaccines Companies Ranked by Revenue 3.3 Global Travelers Vaccines Revenue by Companies 3.4 Global Travelers Vaccines Sales by Companies 3.5 Global Travelers Vaccines Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Travelers Vaccines Companies in Global Market, by Revenue in 2020 3.7 Global Manufacturers Travelers Vaccines Product Type 3.8 Tier 1, Tier 2 and Tier 3 Travelers Vaccines Players in Global Market 3.8.1 List of Global Tier 1 Travelers Vaccines Companies 3.8.2 List of Global Tier 2 and Tier 3 Travelers Vaccines Companies
…
7 Manufacturers & Brands Profiles 7.1 GlaxoSmithKline 7.1.1 GlaxoSmithKline Corporate Summary 7.1.2 GlaxoSmithKline Business Overview 7.1.3 GlaxoSmithKline Travelers Vaccines Major Product Offerings 7.1.4 GlaxoSmithKline Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.1.5 GlaxoSmithKline Key News 7.2 Sanofi Pasteur 7.2.1 Sanofi Pasteur Corporate Summary 7.2.2 Sanofi Pasteur Business Overview 7.2.3 Sanofi Pasteur Travelers Vaccines Major Product Offerings 7.2.4 Sanofi Pasteur Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.2.5 Sanofi Pasteur Key News 7.3 Merck 7.3.1 Merck Corporate Summary 7.3.2 Merck Business Overview 7.3.3 Merck Travelers Vaccines Major Product Offerings 7.3.4 Merck Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.3.5 Merck Key News 7.4 Pfizer 7.4.1 Pfizer Corporate Summary 7.4.2 Pfizer Business Overview 7.4.3 Pfizer Travelers Vaccines Major Product Offerings 7.4.4 Pfizer Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.4.5 Pfizer Key News 7.5 CNBG 7.5.1 CNBG Corporate Summary 7.5.2 CNBG Business Overview 7.5.3 CNBG Travelers Vaccines Major Product Offerings 7.5.4 CNBG Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.5.5 CNBG Key News 7.6 Sanofi Pasteur MSD 7.6.1 Sanofi Pasteur MSD Corporate Summary 7.6.2 Sanofi Pasteur MSD Business Overview 7.6.3 Sanofi Pasteur MSD Travelers Vaccines Major Product Offerings 7.6.4 Sanofi Pasteur MSD Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.6.5 Sanofi Pasteur MSD Key News 7.7 Serum Institute of India 7.7.1 Serum Institute of India Corporate Summary 7.7.2 Serum Institute of India Business Overview 7.7.3 Serum Institute of India Travelers Vaccines Major Product Offerings 7.4.4 Serum Institute of India Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.7.5 Serum Institute of India Key News 7.8 Biokangtai 7.8.1 Biokangtai Corporate Summary 7.8.2 Biokangtai Business Overview 7.8.3 Biokangtai Travelers Vaccines Major Product Offerings 7.8.4 Biokangtai Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.8.5 Biokangtai Key News
Continue…
ABOUT US :
Fusion Market Research is one of the largest collections of market research reports from numerous publishers. We have a team of industry specialists providing unbiased insights on reports to best meet the requirements of our clients. We offer a comprehensive collection of competitive market research reports from a number of global leaders across industry segments.
CONTACT US
PH : +(210) 775-2636
0 notes
Text
Vaccine Market Opportunity Assessment and Forecast up to 2025
The evolution of the vaccines market has increasingly pivoted on enormous advances in science of adjuvants over the past several decades. The strides in human vaccine development especially have been fuelled by ceaseless advances in virology, molecular biology, and immunology.
New immunization routes have been discovered and massive inoculation drives have been supported by governments around the world. With robust support from public health systems in several countries, continued immunization programs have been stridently useful in disease prevention.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=21
The robust long-lasting immunity built on by vaccines has been the major underpinning for their role in preventing a range of diseases. These include diphtheria, pertussis, tetanus, measles, poliomyelitis, rubella, smallpox, sepsis, pneumococcal pneumonia, meningitis, hepatitis B, varicella-zoster, cholera, and tuberculosis. This has made investments in the vaccine market worthwhile in improving the health and wellbeing of humanity. Some of the most lethal conditions for which vaccines have been effective in reducing the burden are malaria, HIV-1, and Mycobacterium tuberculosis (MTB).
The report by TMR see the vaccine market to see substantial revenue potential during the forecast period of 2017 – 2025. The study projects the valuation to climb to 48.0 Bn by 2025.
Request a PDF Sample https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21
Role of Vaccines in Preventing Numerous Childhood Diseases Makes Prospects in Vaccine Market Bright
Recommendations for immunization programs cover both adults and children. Stridently, national healthcare systems in various countries have specific vaccination recommendations in place for newborns and children. Key vaccines administered to polio, meningococcal disease, DTP, and pneumococcal disease. The implementation of recommendations by the medical and the healthcare industries has been on account of the established role of vaccines in preventing multiple viral and bacterial infections. The trend is expected to underpin lucrative gains to players in the global vaccine market.
Recommendations for adult vaccination have also picked up pace, fueling the value chain of players in the vaccine market. Of note, adults who weren’t able to receive certain vaccinations in childhood have become eligible candidates, notably bolstering the demand for vaccines measles, mumps, rubella, and varicella.
Request for Analysis of COVID19 Impact on Vaccines Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=21
R&D for New Mechanisms of Action to Boost Outcomes Expands Vaccine Market Avenue
Advances made in adjuvant system have been a prominent pillar for new array of products in the vaccine market. The number of licensed adjuvants for human vaccine development has risen over the past few years. Global heavyweights in the vaccine market are keenly testing new line of adjuvant systems in clinical trials to tap into the market possibilities, notes a study on the vaccine market. Particularly for the currently emerging Covid-19, a number of adjuvant systems in various phases of clinical trials have been tested for SARS-CoV-2 vaccines, and are in different clinical stages including in Phase 3 trials. Notable examples include Advax and Matrix M. With vaccine developers across the world scrambling to launch vaccines with long-term immunity against SARS-CoV-2, the trend will confer on them incremental opportunities throughout the forecast period. A wide range of vaccine types are under investigation, and the lucrativeness of the pipeline is evident in the emerging demand for booster doses in some countries, such as the U.S.
On the other hand, vast immunization drives in recent months notably in emerging economies has spurred the growth of the vaccine market. This has opened floodgates of opportunities for vaccine research in Asia Pacific.
In low and middle-income countries, such as in the Middle East and Africa, a number of vaccine candidates are being tested for malaria and other debilitating infections. Aside from this, vaccine developers are likely to focus on tropical diseases. On the other hand, T cell vaccines show a promising potential, opening new vistas in vaccine market.
In the coming years, the push for establishing and maintaining herd immunity is a key trend that will greatly influence the contours of the vaccine market.
Buy now Vaccines Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=21<ype=S
The review is based on TMR’s report titled, “Vaccines Market (Vaccine Type - Inactivated, Live Attenuated, Toxoid, Conjugate; Valance - Monovalent, Multivalent; Route of Administration - Oral, Injectable; Indication - Influenza, Hepatitis, Polio, Meningococcal Disease, Pneumococcal Disease, DTP, Rotavirus, MMR, Human Papilloma Virus; Distribution Channel - Institutional Sales, Hospital Pharmacies, Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/rising-patient-pool-and-increasing-healthcare-expenditure-to-invite-favorable-growth-prospects-for-gout-therapeutic-market-during-2019-2027-tmr-301177001.html
https://www.prnewswire.co.uk/news-releases/generic-injectables-market-to-exceed-us-307-bn-value-by-2031-players-focus-on-increasing-patient-compliance-and-new-product-launches-states-tmr-report-829478758.html
https://www.prnewswire.com/news-releases/growing-cases-of-spinal-disorders-to-pain-strokes-of-growth-across-bone-graft-substitutes-market-between-2020-and-2030-tmr-301182424.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact Us
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.co
0 notes
Text
Travelers Vaccines Market Projection By Key players, Size, Trends And Forecast 2021-2027
Travelers Vaccines Market 2021-2027
A New Market Study, Titled “Travelers Vaccines Market Upcoming Trends, Growth Drivers and Challenges” has been featured on fusionmarketresearch.
Description
This global study of the Travelers Vaccines market offers an overview of the existing market trends, drivers, restrictions, and metrics and also offers a viewpoint for important segments. The report also tracks product and services demand growth forecasts for the market. There is also to the study approach a detailed segmental review. A regional study of the global Travelers Vaccines industry is also carried out in North America, Latin America, Asia-Pacific, Europe, and the Near East & Africa. The report mentions growth parameters in the regional markets along with major players dominating the regional growth.
Request a Sample Report @ https://www.fusionmarketresearch.com/sample_request/Travelers-Vaccines-Market/40855
This report contains market size and forecasts of Travelers Vaccines in global, including the following market information: Global Travelers Vaccines Market Revenue, 2016-2021, 2022-2027, ($ millions) Global Travelers Vaccines Market Sales, 2016-2021, 2022-2027, (K Doses) Global top five Travelers Vaccines companies in 2020 (%) The global Travelers Vaccines market was valued at 3180.8 million in 2020 and is projected to reach US$ 4395.4 million by 2027, at a CAGR of 8.4% during the forecast period. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Travelers Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Travelers Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Doses) Global Travelers Vaccines Market Segment Percentages, By Type, 2020 (%) Meningococcal Vaccine Japanese Encephalitis Vaccine Yellow Fever Vaccine Hepatitis Vaccine Cholera Vaccine Other
Competitor Analysis The report also provides analysis of leading market participants including: Key companies Travelers Vaccines revenues in global market, 2016-2021 (Estimated), ($ millions) Key companies Travelers Vaccines revenues share in global market, 2020 (%) Key companies Travelers Vaccines sales in global market, 2016-2021 (Estimated), (K Doses) Key companies Travelers Vaccines sales share in global market, 2020 (%) Further, the report presents profiles of competitors in the market, key players include: GlaxoSmithKline Sanofi Pasteur Merck Pfizer CNBG Sanofi Pasteur MSD Serum Institute of India Biokangtai
Global Travelers Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Doses) Global Travelers Vaccines Market Segment Percentages, By Application, 2020 (%) Tourists Students Workers Others
Global Travelers Vaccines Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Doses) Global Travelers Vaccines Market Segment Percentages, By Region and Country, 2020 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa
Ask Queries @ https://www.fusionmarketresearch.com/enquiry.php/Travelers-Vaccines-Market/40855
Table of Contents
1 Introduction to Research & Analysis Reports 1.1 Travelers Vaccines Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by End Users 1.3 Global Travelers Vaccines Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats
2 Global Travelers Vaccines Overall Market Size 2.1 Global Travelers Vaccines Market Size: 2021 VS 2027 2.2 Global Travelers Vaccines Revenue, Prospects & Forecasts: 2016-2027 2.3 Global Travelers Vaccines Sales (Consumption): 2016-2027
3 Company Landscape 3.1 Top Travelers Vaccines Players in Global Market 3.2 Top Global Travelers Vaccines Companies Ranked by Revenue 3.3 Global Travelers Vaccines Revenue by Companies 3.4 Global Travelers Vaccines Sales by Companies 3.5 Global Travelers Vaccines Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Travelers Vaccines Companies in Global Market, by Revenue in 2020 3.7 Global Manufacturers Travelers Vaccines Product Type 3.8 Tier 1, Tier 2 and Tier 3 Travelers Vaccines Players in Global Market 3.8.1 List of Global Tier 1 Travelers Vaccines Companies 3.8.2 List of Global Tier 2 and Tier 3 Travelers Vaccines Companies
…
7 Manufacturers & Brands Profiles 7.1 GlaxoSmithKline 7.1.1 GlaxoSmithKline Corporate Summary 7.1.2 GlaxoSmithKline Business Overview 7.1.3 GlaxoSmithKline Travelers Vaccines Major Product Offerings 7.1.4 GlaxoSmithKline Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.1.5 GlaxoSmithKline Key News 7.2 Sanofi Pasteur 7.2.1 Sanofi Pasteur Corporate Summary 7.2.2 Sanofi Pasteur Business Overview 7.2.3 Sanofi Pasteur Travelers Vaccines Major Product Offerings 7.2.4 Sanofi Pasteur Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.2.5 Sanofi Pasteur Key News 7.3 Merck 7.3.1 Merck Corporate Summary 7.3.2 Merck Business Overview 7.3.3 Merck Travelers Vaccines Major Product Offerings 7.3.4 Merck Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.3.5 Merck Key News 7.4 Pfizer 7.4.1 Pfizer Corporate Summary 7.4.2 Pfizer Business Overview 7.4.3 Pfizer Travelers Vaccines Major Product Offerings 7.4.4 Pfizer Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.4.5 Pfizer Key News 7.5 CNBG 7.5.1 CNBG Corporate Summary 7.5.2 CNBG Business Overview 7.5.3 CNBG Travelers Vaccines Major Product Offerings 7.5.4 CNBG Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.5.5 CNBG Key News 7.6 Sanofi Pasteur MSD 7.6.1 Sanofi Pasteur MSD Corporate Summary 7.6.2 Sanofi Pasteur MSD Business Overview 7.6.3 Sanofi Pasteur MSD Travelers Vaccines Major Product Offerings 7.6.4 Sanofi Pasteur MSD Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.6.5 Sanofi Pasteur MSD Key News 7.7 Serum Institute of India 7.7.1 Serum Institute of India Corporate Summary 7.7.2 Serum Institute of India Business Overview 7.7.3 Serum Institute of India Travelers Vaccines Major Product Offerings 7.4.4 Serum Institute of India Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.7.5 Serum Institute of India Key News 7.8 Biokangtai 7.8.1 Biokangtai Corporate Summary 7.8.2 Biokangtai Business Overview 7.8.3 Biokangtai Travelers Vaccines Major Product Offerings 7.8.4 Biokangtai Travelers Vaccines Sales and Revenue in Global (2016-2021) 7.8.5 Biokangtai Key News
Continue…
ABOUT US :
Fusion Market Research is one of the largest collections of market research reports from numerous publishers. We have a team of industry specialists providing unbiased insights on reports to best meet the requirements of our clients. We offer a comprehensive collection of competitive market research reports from a number of global leaders across industry segments.
CONTACT US
PH : +(210) 775-2636
0 notes
Text
The Global Meningococcal Vaccines Market Revenue, Gross Margin and Market Share (2021-2027)
Global Meningococcal Vaccines Market was valued at 1,938 million in 2019 which is expected to reach USD 4,196 million by 2027 at CAGR 9.3%.
Meningitis is caused by various fungi, bacteria, and viruses. The bacterial form of meningitis is called as meningococcal meningitis which is caused by Neisseria meningitides (meningococcus) bacteria. Meningococcal meningitis disease is prevented by using meningococcal vaccines.
Get Sample of this Report @ https://qualiketresearch.com/request-sample/Meningococcal-Vaccines-Market/request-sample
Market Segmentation
Global Meningococcal Vaccines Market is segmented into vaccine serotype such as MenAC, MenA, MenC, MenB & Manic, and MenACWY, by vaccine type such as Subcapsular, Polysaccharide, and Conjugate. Further, Global Meningococcal Vaccines Market is segmented into end user such as Adult, Pediatric, and Travelers.
Also, Global Meningococcal Vaccines Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Various key players are discussed in this report such as Serum Institute of India Pvt. Ltd, Emergent BioSolutions, Inc, Sanofi, Merck & Co., Inc, GlaxoSmithKline, plc, and Pfizer Inc.
Market Taxonomy
By Vaccine Serotype
· MenAC
· MenA
· MenC
· MenB
· Manic MenACWY
By Vaccine Type
· Subcapsular
· Polysaccharide
· Conjugate
By End User
· Adult
· Pediatric
· Travelers
By Region
North America
Latin America
Europe Asia
Pacific Middle
East & Africa
Get Details of Global Meningococcal Vaccines Market @ https://qualiketresearch.com/reports-details/Meningococcal-Vaccines-Market
About Us
QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.
0 notes